MarketsSingle-source
2.0
NewAmsterdam Pharma Co N.V. reports executive or director departure
SEC EDGAR 8-K FilingsLO·NL · US·2 days ago
Albemarle Corporation has filed an 8-K disclosing changes to its executive leadership or compensatory arrangements. The filing indicates a material corporate governance update, though specific details regarding the nature of the departures or appointments remain to be extracted from the exhibit documents.
Locations
Entities